SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-012212
Filing Date
2024-02-07
Accepted
2024-02-07 16:15:52
Documents
128
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F asnd-20231231.htm   iXBRL 20-F 5260779
2 EX-2.3 asnd-ex2_3.htm EX-2.3 200028
3 EX-4.22 asnd-ex4_22.htm EX-4.22 397250
4 EX-8.1 asnd-ex8_1.htm EX-8.1 14155
5 EX-11.1 asnd-ex11_1.htm EX-11.1 129588
6 EX-12.1 asnd-ex12_1.htm EX-12.1 10388
7 EX-12.2 asnd-ex12_2.htm EX-12.2 10382
8 EX-13.1 asnd-ex13_1.htm EX-13.1 6004
9 EX-13.2 asnd-ex13_2.htm EX-13.2 6033
10 EX-15.1 asnd-ex15_1.htm EX-15.1 2944
11 EX-97.1 asnd-ex97_1.htm EX-97.1 60694
12 GRAPHIC img80190973_0.jpg GRAPHIC 29018
13 GRAPHIC img147662979_0.jpg GRAPHIC 18701
14 GRAPHIC img147662979_1.jpg GRAPHIC 83364
15 GRAPHIC img147662979_2.jpg GRAPHIC 119103
16 GRAPHIC img147662979_3.jpg GRAPHIC 16130
17 GRAPHIC img147662979_4.jpg GRAPHIC 18522
18 GRAPHIC img147662979_5.jpg GRAPHIC 192260
19 GRAPHIC img147662979_6.jpg GRAPHIC 75487
20 GRAPHIC img147662979_7.jpg GRAPHIC 19607
21 GRAPHIC img147662979_8.jpg GRAPHIC 2510
  Complete submission text file 0000950170-24-012212.txt   20494422

Data Files

Seq Description Document Type Size
22 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asnd-20231231.xsd EX-101.SCH 2121763
130 EXTRACTED XBRL INSTANCE DOCUMENT asnd-20231231_htm.xml XML 3952110
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36815 | Film No.: 24604506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)